News about Research
Three researchers with a 'clinical-scientist' profile join IDIBAPS thanks to the BITRECS-AECC programme
Alberto Orta, Juan José Rodríguez and Ezequiel Mauro joined the BITRECS-AECC programme, that allows for the recruitment of clinician-scientists1
A study demonstrates a lack of solid data on how to deal with the impacts of climate change on mental health
Authored by an international team with the significant involvement of researchers from IDIBAPS-Hospital Clínic Barcelona, JAMA Psychiatry has publish1
Pioneer is not a word: it's a way of doing things
Being pioneers is not just about getting there first; it's about doing so with purpose, with rigour and with a commitment to public service. In recen1
IGNITION gathers its consortium for the online Kick-Off Meeting
The IGNITION consortium, an European project coordinated by Lidia Sabater, researcher at Pathogenesis of autoimmune neuronal disorders IDIBAPS group,1
IDIBAPS-Hospital Clínic Barcelona researchers propose more precise terminology to define neuroimmunological changes in schizophrenia
IDIBAPS’ Schizophrenia research group has published an article in Molecular Psychiatry entitled ‘Neuroinflammation: an unfortunate term to describe s1
The VISI-ON-BRAIN project is launched, a training and research network in neurosciences based on next-generation human models
The project is part of the Horizon Europe programme and has a budget of 4.5 million euros within the framework of the Marie Skłodowska-Curie Doctoral1
The AECC grants more than 1,2 milions euros to IDIBAPS cancer research
Yesterday, Thursday, February 26, the Spanish Association Against Cancer (AECC) held an event in Barcelona to present the research grants awarded for1
Endothelial cell mitochondrial status influences the metabolism of the whole body
A new study, led by the IDIBAPS Neuronal control of metabolism group shows that endothelial cells, which line all of the body’s blood vessels, play a1
Molecular mechanism associated with perianal fistula formation in Crohn's disease is described
A team coordinated by the IDIBAPS-CIBEREHD Inflammatory bowel disease group, led by Azucena Salas, has identified a molecular mechanism that explains1